Truffle’s Entrepreneurial DNA
Truffle Capital in figures
Truffle Capital is a leading European Venture Capital firm based in Paris, with an expertise in the areas of IT/Digital and Life Sciences. Our teams create and build innovating companies, future leaders of their sector who develop disruptive technologies in the areas of FinTech/InsurTech and BioTech/MedTech.
Investments in our portfolio
Years of experience
Truffle Capital Innovation Focus
Truffle Capital focuses its investments in two main areas: FinTech/Insurtech and BioTech/MedTech.
Truffle’s FinTech/InsurTech focus is targeted on Banking, Finance and Insurance technologies. Indeed, since 2001, Truffle Capital is a FinTech pioneer in France, launching the first FinTech incubator in France in 2015, and successfully selling 3 companies out of 8.
The new Truffle Financial Innovation Fund has a target size of 150M€ and will invest between 5 and 20 M€ in 12 to 15 innovating start-ups.
The new Truffle BioMedTech Crossover Fund has a target size of 200 M€; the first closing of this fund took place in November 2017 at 85 M€.
Truffle BioMedTech Crossover Fund will invest in 10 to 12 companies (80% MedTech early stage, 20% BioTech later stage): 3 company creations are currently in progress.
Invest in Truffle Capital Funds
With Truffle Capital, invest in innovative companies which are difficult to access and which have been identified by a team of experts. Our offers (FCPI, holdings, mandates, FPCI…) aim at generating performance whilst optimizing your taxes.
Offers for Private Individuals
Offers for Institutional Investors
Truffle Portfolio Companies
Truffle Capital creates, builds and develops disruptive companies in a wide range of sectors, from IT/FinTech and InsurTech, to BioMedTech. You will find hereunder an excerpt of some of Truffle’s most successful portfolio companies.
Biotech / Medtech
Digital / FinTech
Contact Truffle Capital
5 Rue de la Baume, 75008 Paris, France
Tel: +33 1 82 28 46 00